PMS-DIMETHYL FUMARATE 120 MG
DIMETHYL FUMARATE : 120 MG · DIN 02497026 · PHARMASCIENCE INC
Health Canada status: MARKETED
What is PMS-DIMETHYL FUMARATE?
PMS-DIMETHYL FUMARATE 120 MG contains DIMETHYL FUMARATE : 120 MG. It is listed in the Health Canada Drug Product Database under DIN 02497026, held by PHARMASCIENCE INC, supplied as CAPSULE (DELAYED RELEASE) for ORAL administration. Health Canada currently lists it as marketed, status dated 04-Oct-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02497026 |
|---|---|
| Brand name | PMS-DIMETHYL FUMARATE |
| Generic / active ingredient | DIMETHYL FUMARATE : 120 MG |
| Manufacturer | PHARMASCIENCE INC |
| Strength | 120 MG |
| Dosage form | CAPSULE (DELAYED RELEASE) |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | L04AX07 DIMETHYL FUMARATE |
| AHFS class | 92:20.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 04-Oct-2021 |
| Original market date | 2021-10-04 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code L04AX07 DIMETHYL FUMARATE. 12 of 22 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-DIMETHYL FUMARATE | 120 MG | CAPSULE (DELAYED RELEASE) | APOTEX INC | MARKETED | DIN 02505762 |
| APO-DIMETHYL FUMARATE | 240 MG | CAPSULE (DELAYED RELEASE) | APOTEX INC | MARKETED | DIN 02505770 |
| AURO-DIMETHYL FUMARATE | 120 MG | CAPSULE (DELAYED RELEASE) | AURO PHARMA INC | MARKETED | DIN 02540746 |
| AURO-DIMETHYL FUMARATE | 240 MG | CAPSULE (DELAYED RELEASE) | AURO PHARMA INC | MARKETED | DIN 02540754 |
| JAMP DIMETHYL FUMARATE | 120 MG | CAPSULE (DELAYED RELEASE) | JAMP PHARMA CORPORATION | MARKETED | DIN 02516047 |
| JAMP DIMETHYL FUMARATE | 240 MG | CAPSULE (DELAYED RELEASE) | JAMP PHARMA CORPORATION | MARKETED | DIN 02516055 |
| MAR-DIMETHYL FUMARATE | 120 MG | CAPSULE (DELAYED RELEASE) | MARCAN PHARMACEUTICALS INC | MARKETED | DIN 02502690 |
| MAR-DIMETHYL FUMARATE | 240 MG | CAPSULE (DELAYED RELEASE) | MARCAN PHARMACEUTICALS INC | MARKETED | DIN 02502704 |
| PMS-DIMETHYL FUMARATE | 240 MG | CAPSULE (DELAYED RELEASE) | PHARMASCIENCE INC | MARKETED | DIN 02497034 |
| TECFIDERA | 120 MG | CAPSULE (DELAYED RELEASE) | BIOGEN CANADA INC | MARKETED | DIN 02404508 |
Who else supplies DIMETHYL FUMARATE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. DIMETHYL FUMARATE appears in 166 registered pack listings across 9 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.